论文部分内容阅读
目的:分析功能性消化不良患者行多潘立酮、复方消化酶联合疗法的效果。方法:从我院所收治的众多功能性消化不良患者中抽选120例,将其分成多潘立酮对照组、多潘立酮联合复方消化酶研究组,评定预后的临床效果。结果:研究组预后的疾病效果为96.7%(58/60),高于对照组的83.3%(50/60),P<0.05,统计学有区别。结论:临床针对功能性消化不良患者实施多潘立酮、复方消化酶疗法作用显著,可缓解病症,增强疗效,值得借鉴。
Objective: To analyze the effect of combined treatment of domperidone and compound digestive enzymes in functional dyspepsia patients. Methods: A total of 120 patients with functional dyspepsia were selected from our hospital and divided into domperidone control group and domperidone combined with compound digestive enzyme group to evaluate the clinical effect of prognosis. Results: The prognosis of the study group was 96.7% (58/60), higher than 83.3% (50/60) in the control group, P <0.05, statistically significant. Conclusion: The clinical treatment of patients with functional dyspepsia domperidone, compound digestive enzyme therapy is significant, can alleviate the symptoms and enhance efficacy, it is worth learning from.